NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

China is an essential link in the global pharma supply chain as the key supplier of drug ingredients for the world's drugmakers. But the country's vast industry and hit-and-miss government oversight poses special challenges for drug regulators who too often find companies there skirting the standards they expect. For the…

news

The 32-year-old Pharmascience Inc., Canada’s third-ranking pharmaceutical group, is investing $55.7 million over the next 18 months to upgrade its Montreal research, manufacturing and distribution operations and speed growth. “This project, along with several other recent investments, confirms Quebec’s life sciences sector is beginning to recover after a severe downturn,”…

news

Drug firm Wockhardt has received approval from the US health regulator to market its Oxycodone HCl liquid, used for treating chronic pain, in the American market. The company has received final approval from the US Food and Drug Administration (USFDA) to market 5mg/5ml of Oxycodone HCl liquid, Wockhardt Ltd said…

news

Vaxon Biotech, a company specialized in anti-tumour immunotherapy, has been granted patent in Japan for Vbx-026, a new cancer vaccine for solid tumours. This patent (JP application no 2012-502822) covers a series of optimized cryptic peptides to be used in the design of the Vbx-026. This patent gives Vaxon exclusive…

news

The U.S. Food and Drug Administration approved Medicines Co's blood clot preventer Cangrelor on Monday, close to a decade after the drug first entered late-stage studies. Cangrelor is an intravenous threpay aimed at preventing blood clots in patients who need percutaneous coronary intervention (PCI) or angioplasty - a non-surgical procedure…

news

Intas Pharmaceuticals, a vertically integrated pharma company, today said it expects to launch its first biosimilar in the US within 9-12 months. Intas is the only domestic firm with two biosimilars filed for registration in the US and it looks to deliver affordable and innovative pharmaceutical solutions in India, the…

news

Aurobindo Pharma Ltd has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Entacapone tablets. The product will be launched soon, the Hyderabad-based company said in a release issued here on Monday. . The approved product is bioequivalent and therapeutically equivalent to the reference…

news

Santhera Pharmaceuticals Holding AG : * Appoints Chief Financial Officer * Appoints Christoph Rentsch as CFO and member of executive management team.   reuters.com

news

Strides Arcolab plans to approach Foreign Investment Promotion Board (FIPB) after the government rejected its proposal to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals. "The company is proposing to make a representation to FIPB," Strides Arcolab said in a BSE filing. Strides Arcolab said it has…

news

China has rejected Gilead Sciences Inc's application for a new patent related to its costly hepatitis C drug Sovaldi, removing a potential barrier to generic versions of the drug there, a U.S. legal group announced on Friday. The New York-based group, Initiative for Medicines, Access & Knowledge, or I-MAK, challenged…